Role of TJP1 in Sensitivity and Resistance to Proteasome Inhibitors in Myeloma

Irene M. Ghobrial

The role of miRNA15a and 16-1 in Multiple Myeloma

Multiple myeloma and immunoproliferative diseases

Daniel M Sullivan

CRM1 INHIBITORS SENSITIZE MULTIPLE MYELOMA CELLS TO TOPOISOMERASE II AND PROTEASOME INHIBITORS

Multiple myeloma and immunoproliferative diseases

Jens G Lohr

Determining the mutational landscape of circulating multiple myeloma cells

Multiple myeloma and immunoproliferative diseases

Pathology

Jing Yang

Targeting adipocyte-secreted chemerin for chemotherapy resistance in myeloma

Multiple myeloma and immunoproliferative diseases

Richard A Flavell

Understanding Hemotopoietic Neoplasias using Humanized Mice

Multiple myeloma and immunoproliferative diseases

Hematology and hematologic malignancies Pathology

Jetze J Tepe

Characterization of Non-Competitive Proteasome Binding

Multiple myeloma and immunoproliferative diseases

Hematology and hematologic malignancies Pathology

Sarah A Holstein

Rab Geranylgeranylation: a Novel Therapeutic Target in Multiple Myeloma

Multiple myeloma and immunoproliferative diseases

Kelvin P. Lee

CD28-mediated Regulation of Multiple Myeloma Cell Proliferation and Survival

Multiple myeloma and immunoproliferative diseases

Ralph D Sanderson

Heparanase Regulation of Myeloma Metastasis: Mechanism and Therapy

Multiple myeloma and immunoproliferative diseases

Hematology and hematologic malignancies